SCHEMBL22952976

SCHEMBL22952976

Cc1ncc2c3c1Oc1c(ccc(O)c1O)C3CNC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.33
PARP1 P09874 1/20 0.33
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CYP3A4 P08684 2/20 0.30
MAPK1 P28482 2/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
THPO P40225 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 1/20 0.30
CYP2D6 P10635 1/20 0.30
KMT2A Q03164 1/20 0.30
ADCY5 O95622 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952977 0.85 DRD1 (0.33) HTR2APARP1DRD2DRD1SLC6A4
SCHEMBL22952975 0.82 DRD2 (0.36) DRD2DRD1SLC6A2SLC6A4SLC6A3
SCHEMBL22952973 0.79 PARP1 (0.38) PARP1CYP3A4MAPK1ALOX15TSHR
SCHEMBL22952971 0.79 HTR2A (0.35) HTR2APARP1DRD2DRD1CYP3A4
SCHEMBL22953390 0.78 HTR2A (0.36) HTR2APARP1DRD2DRD1
SCHEMBL6345215 0.74 HTR2A (0.46) HTR2APARP1DRD2DRD1CYP3A4
SCHEMBL29383649 0.74 HTR2A (0.46) HTR2APARP1DRD2DRD1CYP3A4
SCHEMBL22953343 0.74 PARP1 (0.41) PARP1DRD2DRD1CYP3A4MAPK1
Bromide SCHEMBL3668719 0.73 HTR2A (0.45) HTR2APARP1DRD2DRD1CYP3A4
SCHEMBL22953344 0.69 PARP1 (0.39) PARP1DRD1CYP3A4MAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed